Loading... Please wait...

INmune Bio, Inc. (INMB) Financials

Currency in USD Disclaimer
$7.99 -$0.08 (-0.99%)
$7.83
$8.2
$6.5
$14.74
Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $155,000.00 $374,000.00 $181,000.00 $10,916.00 $77.69 M $0.00 $0.00 $0.00
Cost of Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $155,000.00 $374,000.00 $181,000.00 $10,916.00 $77.69 M $0.00 $0.00 $0.00
Gross Profit Ratio 1 1 1 1 1 0 0 0
Research and Development Expenses $20.27 M $17.07 M $20.54 M $5.92 M $3.28 M $1.11 M $435,362.00 $101,495.00
General & Administrative Expenses $9.62 M $9.26 M $8.79 M $6.32 M $6.02 M $11.33 M $546,118.00 $125,996.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $9.62 M $9.26 M $8.79 M $6.32 M $6.02 M $11.33 M $546,118.00 $125,996.00
Other Expenses -$267,000.00 -$1.35 M -$1.19 M $128,517.00 $0.00 $0.00 -$6.00 $0.00
Operating Expenses $29.90 M $26.33 M $29.33 M $12.24 M $9.30 M $12.44 M $981,480.00 $227,491.00
Cost And Expenses $29.90 M $26.33 M $29.33 M $12.24 M $9.30 M $12.44 M $981,480.00 $227,491.00
Interest Income $0.00 $0.00 $0.00 $0.00 $77,688.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $1.35 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $29.74 M $25.86 M $29.15 M $12.23 M -$3.08 M $0.00 -$150,000.00 $50,000.00
EBITDA -$29.74 M -$25.95 M -$29.15 M -$12.23 M -$10.84 M -$12.44 M -$1.13 M -$177,491.00
EBITDA Ratio -191.88 -69.39 -161.07 -1120.16 -0.14 0 0 0
Operating Income -$29.74 M -$25.95 M -$29.15 M -$12.23 M -$7.76 M -$12.44 M -$981,480.00 -$227,491.00
Operating Income Ratio -191.88 -69.39 -161.07 -1120.16 -0.1 0 0 0
Total Other Income/Expenses Net -$267,000.00 -$1.35 M -$1.19 M $128,517.00 $77,688.00 $0.00 $149,994.00 -$50,000.00
Income Before Tax -$30.01 M -$27.30 M -$30.34 M -$12.10 M -$7.68 M -$12.44 M -$831,486.00 -$277,491.00
Income Before Tax Ratio -193.6 -72.99 -167.62 -1108.39 -0.1 0 0 0
Income Tax Expense -$29.74 M $1.35 M -$29.15 M -$12.23 M $1.46 M $0.00 $0.00 $0.00
Net Income -$30.01 M -$28.65 M -$30.34 M -$12.10 M -$9.14 M -$12.44 M -$831,486.00 -$277,491.00
Net Income Ratio -193.6 -76.6 -167.62 -1108.39 -0.12 0 0 0
EPS -1.67 -1.6 -1.88 -1.01 -0.89 -1.11 -0.0741 -0.0247
EPS Diluted -1.67 -1.6 -1.88 -1.01 -0.89 -1.11 -0.0741 -0.0247
Weighted Average Shares Out $17.98 M $17.93 M $16.13 M $11.99 M $10.27 M $11.22 M $11.22 M $11.22 M
Weighted Average Shares Out Diluted $17.98 M $17.93 M $16.13 M $11.99 M $10.27 M $11.22 M $11.22 M $11.22 M
Link
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.